{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:50:04Z","timestamp":1789469404762,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3506700"],"award-info":[{"award-number":["2024YFC3506700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00044-026-03576-9","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:20:28Z","timestamp":1779960028000},"page":"1186-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, Synthesis and Antitumor Activity Evaluation in Vitro of Novel 1,6-Naphthyridine Derivatives"],"prefix":"10.1007","volume":"35","author":[{"given":"Xiao-Jie","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motahareh","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Guo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"3576_CR1","doi-asserted-by":"publisher","unstructured":"Cai M, Ni W-J, Wang Y-H, Wang J-J, Zhou H. Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.906372.","DOI":"10.3389\/fonc.2022.906372"},{"issue":"8","key":"3576_CR2","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.4240\/wjgs.v16.i8.2374","volume":"16","author":"C Jiang","year":"2024","unstructured":"Jiang C, Zhang Z-H, Li J-X. Consideration on immunotherapy of liver metastases of malignant tumors. World J Gastrointest Surg. 2024;16(8):2374\u201381. https:\/\/doi.org\/10.4240\/wjgs.v16.i8.2374.","journal-title":"World J Gastrointest Surg"},{"key":"3576_CR3","doi-asserted-by":"publisher","unstructured":"He H, Shao X, Li Y, Gihu R, Xie H, Zhou J, et al. Targeting Signaling Pathway Networks in Several Malignant Tumors: Progresses and Challenges. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.675675.","DOI":"10.3389\/fphar.2021.675675"},{"issue":"1","key":"3576_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A Cancer statistics, 2020. Cancer J Clin. 2020;70(1):7\u201330. . https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"Cancer J Clin"},{"issue":"1","key":"3576_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cas.70229","volume":"117","author":"T Ikawa","year":"2025","unstructured":"Ikawa T, Nakata K, Morishima T, Yoshida Ki, Kuwabara Y, Kato MS, et al. Secondary Lower-Body Sarcomas in Cervical Cancer Survivors Following Surgery, Radiotherapy, or Both: A Population\u2010Based Study. Cancer Sci. 2025;117(1):216\u201325. https:\/\/doi.org\/10.1111\/cas.70229.","journal-title":"Cancer Sci"},{"key":"3576_CR6","doi-asserted-by":"publisher","unstructured":"Jain SM, Nagainallur Ravichandran S, Murali Kumar M, Banerjee A, Sun-Zhang A, Zhang H, et al. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review. Cancer Biol Ther. 2024;25(1). https:\/\/doi.org\/10.1080\/15384047.2024.2317999.","DOI":"10.1080\/15384047.2024.2317999"},{"issue":"S1","key":"3576_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/jog.16028","volume":"50","author":"T Morisada","year":"2024","unstructured":"Morisada T. Latest findings in chemotherapy. J Obstet Gynecol Res. 2024;50(S1):79\u201383. https:\/\/doi.org\/10.1111\/jog.16028.","journal-title":"J Obstet Gynecol Res"},{"issue":"4","key":"3576_CR8","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/s1470-2045(18)30094-9","volume":"19","author":"SN Weingart","year":"2018","unstructured":"Weingart SN, Zhang L, Sweeney M, Hassett M. Chemotherapy medication errors. Lancet Oncol. 2018;19(4):e191\u20139. https:\/\/doi.org\/10.1016\/s1470-2045(18)30094-9.","journal-title":"Lancet Oncol"},{"key":"3576_CR9","doi-asserted-by":"publisher","unstructured":"Zhou B, Liu J, Lin M, Zhu J, Chen WR. Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy. Coord Chem Rev. 2021;442. https:\/\/doi.org\/10.1016\/j.ccr.2021.214009.","DOI":"10.1016\/j.ccr.2021.214009"},{"issue":"5","key":"3576_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrclinonc.2018.27","volume":"15","author":"JC Del Paggio","year":"2018","unstructured":"Del Paggio JC. Cancer immunotherapy and the value of cure. Nat Reviews Clin Oncol. 2018;15(5):268\u201370. https:\/\/doi.org\/10.1038\/nrclinonc.2018.27.","journal-title":"Nat Reviews Clin Oncol"},{"key":"3576_CR11","doi-asserted-by":"publisher","unstructured":"Zhou Z, Li M. Targeted therapies for cancer. BMC Med. 2022;20(1). https:\/\/doi.org\/10.1186\/s12916-022-02287-3.","DOI":"10.1186\/s12916-022-02287-3"},{"issue":"10","key":"3576_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s43018-023-00664-2","volume":"4","author":"The never-abating excitement for targeted therapies","year":"2023","unstructured":"The never-abating excitement for targeted therapies. Nat Cancer. 2023;4(10):1397\u20138. https:\/\/doi.org\/10.1038\/s43018-023-00664-2.","journal-title":"Nat Cancer"},{"key":"3576_CR13","doi-asserted-by":"publisher","unstructured":"Cheng C-F, Lu C-W, Wu W-J, Su L-Y, Nguyen TKN, Shen S-C, et al. Therapeutic Effects of Plant Extracts of Anoectochilus roxburghii on Side Effects of Chemotherapy in BALB\/c Breast Cancer Mice. Plants. 2023;12(13). https:\/\/doi.org\/10.3390\/plants12132494.","DOI":"10.3390\/plants12132494"},{"key":"3576_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5548968","volume":"2021","author":"C-Y Lien","year":"2021","unstructured":"Lien C-Y, Lu C-W, Lin Y-H, Wu W-J, Hsu C-H, Chuang T-Y, et al. Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models. Evidence-Based Complement Altern Med. 2021;2021:1\u201311. https:\/\/doi.org\/10.1155\/2021\/5548968.","journal-title":"Evidence-Based Complement Altern Med"},{"key":"3576_CR15","doi-asserted-by":"publisher","unstructured":"Xie X, Wang Y, Wang Z, Zhang L, Li J, Li Y. Hepatocellular carcinoma drug resistance models. Cancer Cell Int. 2025;25(1). https:\/\/doi.org\/10.1186\/s12935-025-03821-y.","DOI":"10.1186\/s12935-025-03821-y"},{"issue":"5","key":"3576_CR16","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s43440-020-00138-7","volume":"72","author":"T Haider","year":"2020","unstructured":"Haider T, Pandey V, Banjare N, Gupta PN, Soni V. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep. 2020;72(5):1125\u201351. https:\/\/doi.org\/10.1007\/s43440-020-00138-7.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"3576_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10311-015-0494-6","volume":"13","author":"AM Abdel Hameed","year":"2015","unstructured":"Abdel Hameed AM. Rapid synthesis of 1,6-naphthyridines by grindstone chemistry. Environ Chem Lett. 2015;13(1):125\u20139. https:\/\/doi.org\/10.1007\/s10311-015-0494-6.","journal-title":"Environ Chem Lett"},{"issue":"4","key":"3576_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1080\/10406638.2020.1781211","volume":"42","author":"HM Faidallah","year":"2020","unstructured":"Faidallah HM, Sobahi TR, Alharbi AS, El-Avia KM. Multi-Step Synthesis of Biologically Active NovelN-Benzyl-3,5-Bis(Arylidene)-Piperidin-4-Ones and Some Derived Bicyclic and Tricyclic Ring Systems as Macromolecules. Polycycl Aromat Compd. 2020;42(4):1479\u201395. https:\/\/doi.org\/10.1080\/10406638.2020.1781211.","journal-title":"Polycycl Aromat Compd"},{"issue":"9","key":"3576_CR19","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1039\/c2ob26710a","volume":"11","author":"Y Wang","year":"2013","unstructured":"Wang Y, Xu Z-L, Ai J, Peng X, Lin J-P, Ji Y-C, et al. Investigation on the 1,6-naphthyridine motif: discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors. Org Biomol Chem. 2013;11(9):1545\u201362. https:\/\/doi.org\/10.1039\/c2ob26710a.","journal-title":"Org Biomol Chem"},{"key":"3576_CR20","doi-asserted-by":"publisher","unstructured":"Anuradha BS. Epur Manoj Kumar Reddy. Antimicrobial activity of novel naphthyridine compounds. Res J Biotech. 2022;17(10). https:\/\/doi.org\/10.25303\/1710rjbt18025.","DOI":"10.25303\/1710rjbt18025"},{"issue":"10","key":"3576_CR21","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/s0960-894x(03)00288-9","volume":"13","author":"NE Austin","year":"2003","unstructured":"Austin NE, Hadley MS, Harling JD, Harrington FP, Macdonald GJ, Mitchell DJ, et al. The design of 8,8-Dimethyl[1,6]naphthyridines as potential anticonvulsant agents. Bioorg Med Chem Lett. 2003;13(10):1627\u20139. https:\/\/doi.org\/10.1016\/s0960-894x(03)00288-9.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"3576_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.bmcl.2006.11.080","volume":"17","author":"MS Egbertson","year":"2007","unstructured":"Egbertson MS, Moritz HM, Melamed JY, Han W, Perlow DS, Kuo MS, et al. A potent and orally active HIV-1 integrase inhibitor. Bioorg Med Chem Lett. 2007;17(5):1392\u20138. https:\/\/doi.org\/10.1016\/j.bmcl.2006.11.080.","journal-title":"Bioorg Med Chem Lett"},{"issue":"16","key":"3576_CR23","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.bmcl.2015.05.082","volume":"25","author":"J-F Wu","year":"2015","unstructured":"Wu J-F, Liu M-M, Huang S-X, Wang Y. Design and synthesis of novel substituted naphthyridines as potential c-Met kinase inhibitors based on MK-2461. Bioorg Med Chem Lett. 2015;25(16):3251\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2015.05.082.","journal-title":"Bioorg Med Chem Lett"},{"key":"3576_CR24","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0960-894X(00)00568-0","volume":"10","author":"L Guy Falardeau","year":"2000","unstructured":"Guy Falardeau L, Chan T, Stefanac S, May H, Jin. Jean-Franc\u00cbois Lavalle\u00c2 e. Substituted 1,6-Naphthyridines as Human Cytomegalovirus Inhibitors: Conformational Requirements. Bioorg Med Chem Lett. 2000;10:2769\u201370.","journal-title":"Bioorg Med Chem Lett"},{"issue":"24","key":"3576_CR25","doi-asserted-by":"publisher","first-page":"8716","DOI":"10.1021\/jm101048k","volume":"53","author":"E Kiselev","year":"2010","unstructured":"Kiselev E, Dexheimer TS, Pommier Y, Cushman M. Design, Synthesis, and Evaluation of Dibenzo[c,h][1,6]naphthyridines as Topoisomerase I Inhibitors and Potential Anticancer Agents. J Med Chem. 2010;53(24):8716\u201326. https:\/\/doi.org\/10.1021\/jm101048k.","journal-title":"J Med Chem"},{"issue":"6","key":"3576_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acsmedchemlett.4c00156","volume":"15","author":"D Li","year":"2024","unstructured":"Li D, Xie Q, Yang M, Cai Y, Sun K, Jiang S, et al. Lead Identification of Novel Naphthyridine Derivatives as Potent SOS1 Inhibitors. Acs Med Chem Lett. 2024;15(6):958\u201364. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00156.","journal-title":"Acs Med Chem Lett"},{"key":"3576_CR27","doi-asserted-by":"publisher","unstructured":"Qing L, Cheng Z, Xu J, Wang Z, Li Y, Gauthier M, et al. Novel potent SOS1 inhibitors containing a tricyclic quinazoline scaffold: A joint view of experiments and simulations. Eur J Med Chem. 2025;282. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117065.","DOI":"10.1016\/j.ejmech.2024.117065"},{"issue":"8","key":"3576_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","volume":"16","author":"K Aldape","year":"2019","unstructured":"Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, et al. Challenges to curing primary brain tumours. Nat Reviews Clin Oncol. 2019;16(8):509\u201320. https:\/\/doi.org\/10.1038\/s41571-019-0177-5.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3576_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.trecan.2020.01.009","volume":"6","author":"BC Prager","year":"2020","unstructured":"Prager BC, Bhargava S, Mahadev V, Hubert CG, Rich JN. Glioblastoma Stem Cells: Driving Resilience through Chaos. Trends Cancer. 2020;6(3):223\u201335. https:\/\/doi.org\/10.1016\/j.trecan.2020.01.009.","journal-title":"Trends Cancer"},{"issue":"4","key":"3576_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cpt.2023.11.006","volume":"2","author":"V Patel","year":"2024","unstructured":"Patel V, Chavda V. Intraoperative glioblastoma surgery-current challenges and clinical trials: An update. Cancer Pathogenesis Therapy. 2024;2(4):256\u201367. https:\/\/doi.org\/10.1016\/j.cpt.2023.11.006.","journal-title":"Cancer Pathogenesis Therapy"},{"issue":"4","key":"3576_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"P Giuseppa","year":"2016","unstructured":"Giuseppa P. Alessia Garufi Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. AGING. 2016;8(4):603\u201319.","journal-title":"AGING"},{"issue":"3","key":"3576_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3892\/ol.2016.5535","volume":"13","author":"M Qiu","year":"2017","unstructured":"Qiu M, Chen L, Tan G, Ke L, Zhang S, Chen H, et al. JS-K promotes apoptosis by inducing ROS production in human prostate cancer cells. Oncol Lett. 2017;13(3):1137\u201342. https:\/\/doi.org\/10.3892\/ol.2016.5535.","journal-title":"Oncol Lett"},{"key":"3576_CR33","doi-asserted-by":"publisher","unstructured":"Xue D-F, Pan S-T, Huang G, Qiu J-X. ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells. Int J Biochem Cell Biol. 2020;122. https:\/\/doi.org\/10.1016\/j.biocel.2020.105732.","DOI":"10.1016\/j.biocel.2020.105732"},{"key":"3576_CR34","doi-asserted-by":"publisher","unstructured":"An X, Yu W, Liu J, Tang D, Yang L, Chen X. Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis. 2024;15(8). https:\/\/doi.org\/10.1038\/s41419-024-06939-5.","DOI":"10.1038\/s41419-024-06939-5"},{"key":"3576_CR35","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7143","author":"G Liu","year":"2017","unstructured":"Liu G, Liu Z, Yan Y, Wang H. Effect of fraxetin on proliferation and apoptosis in breast cancer cells. Oncol Lett. 2017. https:\/\/doi.org\/10.3892\/ol.2017.7143.","journal-title":"Oncol Lett"},{"issue":"6","key":"3576_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cbin.11137","volume":"43","author":"MS D\u2019Arcy","year":"2019","unstructured":"D\u2019Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582\u201392. https:\/\/doi.org\/10.1002\/cbin.11137.","journal-title":"Cell Biol Int"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03576-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03576-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03576-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:47:13Z","timestamp":1782380833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03576-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3576"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03576-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8736347\/v1","asserted-by":"object"}]},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}